Connect with us

Health

Scientists working on vaccine says Government is creating 'false expectations' – Yahoo Style

Published

 on


In this photo issued by 10 Downing Street, Britain's Business, Energy and Industrial Strategy Secretary Alok Sharma speaks during a coronavirus media briefing in Downing Street, London, Tuesday, May 12, 2020. (Pippa Fowles/10 Downing Street via AP)
Business Secretary Alok Sharma speaks during a coronavirus media briefing in Downing Street last week. (AP)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="A scientist working on a possible COVID-19 vaccine says the government is creating “false expectations” after it touted that 30 million doses could be made for Britain by September.” data-reactid=”32″>A scientist working on a possible COVID-19 vaccine says the government is creating “false expectations” after it touted that 30 million doses could be made for Britain by September.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Ministers announced a deal between a team at Oxford University and the drugmaker AstraZeneca on Sunday, along with pledging £65.5 million in additional funding for the coronavirus vaccine project.” data-reactid=”33″>Ministers announced a deal between a team at Oxford University and the drugmaker AstraZeneca on Sunday, along with pledging £65.5 million in additional funding for the coronavirus vaccine project.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Business secretary Alok Sharma said the team could deliver 100 million doses in total if ongoing trials succeed, along with the September time frame.” data-reactid=”34″>Business secretary Alok Sharma said the team could deliver 100 million doses in total if ongoing trials succeed, along with the September time frame.

However Professor Robin Shattock, head of mucosal infection and immunity at Imperial College London, said it is “important not to have a false expectation that it is just around the corner”.

“It’s highly unlikely that a vaccine will be available for use by September,” he told BBC News.

“Generating doses of the vaccine is very different to having the necessary data to show that any vaccine is both safe and effective against COVID-19.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Professor Shattock, who is leading his own team at Imperial College for finding a vaccine, said there are a number of factors to consider before a vaccine is deemed safe and effective enough to be rolled out nationwide.” data-reactid=”42″>Professor Shattock, who is leading his own team at Imperial College for finding a vaccine, said there are a number of factors to consider before a vaccine is deemed safe and effective enough to be rolled out nationwide.

“It will be critical to build the evidence base to show a vaccine works before it’s deployed,” he said. “This takes time and is dependent on seeing a difference in the number of infections between active vaccine and a placebo.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Latest coronavirus news, updates and advice” data-reactid=”44″>Latest coronavirus news, updates and advice

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Live: Follow all the latest updates from the UK and around the world” data-reactid=”45″>Live: Follow all the latest updates from the UK and around the world

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Fact-checker: The number of COVID-19 cases in your local area” data-reactid=”46″>Fact-checker: The number of COVID-19 cases in your local area

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="6 charts and maps that explain how COVID-19 is spreading” data-reactid=”47″>6 charts and maps that explain how COVID-19 is spreading

“The lower the transmission rate in the UK, the longer it will take to generate such data.

“While UK scientists are actively working on different vaccine approaches, there is no guarantee that any individual approach will work.

“It’s important not to create false expectations ahead of any breakthrough, where the evidence will speak for itself.”

Sharma said on Sunday that Shattock’s team at Imperial College London was “making good progress” and would look to move into clinical trials for a vaccine by mid-June, with larger-scale trials in October.

But Shattock said there is “no certainty” a vaccine will ever be created and that his optimistic estimation is “sometime next year”.

Reguis Professor of Medicine at the University of Oxford Sir John Bell speaks at the launch of the life sciences industrial strategy at the University of Birmingham's Institute of Translational Medicine, in Birmingham.Reguis Professor of Medicine at the University of Oxford Sir John Bell speaks at the launch of the life sciences industrial strategy at the University of Birmingham's Institute of Translational Medicine, in Birmingham.
Professor Sir John Bell, regius professor of medicine at Oxford University, said he was ‘immensely proud’ of the Oxford team’s work. (Getty)

He said: “I think we have a very high chance of seeing a number of vaccines that work because we know a lot about this target and I think there’s good scientific rationale to say it’s not such a hard target as others.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Read more: 5 facts about Alok Sharma, new UK business secretary” data-reactid=”69″>Read more: 5 facts about Alok Sharma, new UK business secretary

“My gut feeling is that we will start to see a number of candidates coming through with good evidence early towards next year – possibly something this year – but they won’t be readily available for wide-scale use into the beginning of next year as the kind of most optimistic estimation.”

Sharma echoed this warning yesterday, saying there are no certainties and that it is possible trials may not lead to a successful coronavirus vaccine.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="He said that so far the government had invested £47m in the Oxford and Imperial vaccine programmes, and announced a further £84m in new funding “to help accelerate their work”.” data-reactid=”74″>He said that so far the government had invested £47m in the Oxford and Imperial vaccine programmes, and announced a further £84m in new funding “to help accelerate their work”.

“This new money will help mass-produce the Oxford vaccine so that if current trials are successful we have dosages to start vaccinating the UK population straightaway,” he said.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Read more: ‘High chance’ of coronavirus vaccine being developed, expert says” data-reactid=”76″>Read more: ‘High chance’ of coronavirus vaccine being developed, expert says

The business secretary said the speed at which Oxford was pushing ahead with development was “genuinely unprecedented” and that the first clinical trials were “progressing well”.

Dr Alexander Douglas, leader of the research group at Oxford that has developed the manufacturing method, said: ‘We have been preparing for large-scale manufacturing of our vaccine candidate since February.

“This funding enables manufacturing to start immediately, and so will make vaccine available as soon as possible, while adhering to the most stringent safety standards.

“The methods developed here in the UK will also enable the production of vaccine for other countries.”

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Read more: Government ‘will make schools decision just four days before planned reopening date’” data-reactid=”87″>Read more: Government ‘will make schools decision just four days before planned reopening date’

Professor Sir John Bell, regius professor of medicine at Oxford University, said: ‘The University of Oxford is immensely proud of the scientists at the Jenner Institute and the Oxford Vaccine Group who have worked tirelessly to discover and develop this vaccine in record time. “

Coronavirus: what happened today

<h3 class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Click here to sign up to the latest news, advice and information with our daily Catch-up newsletter” data-reactid=”90″>Click here to sign up to the latest news, advice and information with our daily Catch-up newsletter

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Biden’s vaccine pledge ups pressure on rich countries to give more

Published

 on

The United States on Thursday raised the pressure on other Group of Seven leaders to share their vaccine hoards to bring an end to the pandemic by pledging to donate 500 million doses of the Pfizer coronavirus vaccine to the world’s poorest countries.

The largest ever vaccine donation by a single country will cost the United States $3.5 billion but Washington expects no quid pro quo or favours for the gift, a senior Biden administration official told reporters.

U.S. President Joe Biden‘s move, on the eve of a summit of the world’s richest democracies, is likely to prompt other leaders to stump up more vaccines, though even vast numbers of vaccines would still not be enough to inoculate all of the world’s poor.

G7 leaders want to vaccinate the world by the end of 2022 to try to halt the COVID-19 pandemic that has killed more than 3.9 million people and devastated the global economy.

A senior Biden administration official described the gesture as a “major step forward that will supercharge the global effort” with the aim of “bringing hope to every corner of the world.” “We really want to underscore that this is fundamentally about a singular objective of saving lives,” the official said, adding that Washington was not seeking favours in exchange for the doses.

Vaccination efforts so far are heavily correlated with wealth: the United States, Europe, Israel and Bahrain are far ahead of other countries. A total of 2.2 billion people have been vaccinated so far out of a world population of nearly 8 billion, based on Johns Hopkins University data.

U.S. drugmaker Pfizer and its German partner BioNTech have agreed to supply the U.S. with the vaccines, delivering 200 million doses in 2021 and 300 million doses in the first half of 2022.

The shots, which will be produced at Pfizer’s U.S. sites, will be supplied at a not-for-profit price.

“Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,” said Pfizer Chief Executive Albert Bourla.

‘DROP IN THE BUCKET’

Anti-poverty campaign group Oxfam called for more to be done to increase global production of vaccines.

“Surely, these 500 million vaccine doses are welcome as they will help more than 250 million people, but that’s still a drop in the bucket compared to the need across the world,” said Niko Lusiani, Oxfam America’s vaccine lead.

“We need a transformation toward more distributed vaccine manufacturing so that qualified producers worldwide can produce billions more low-cost doses on their own terms, without intellectual property constraints,” he said in a statement.

Another issue, especially in some poor countries, is the infrastructure for transporting the vaccines which often have to be stored at very cold temperatures.

Biden has also backed calls for a waiver of some vaccine intellectual property rights but there is no international consensus yet on how to proceed.

The new vaccine donations come on top of 80 million doses Washington has already pledged to donate by the end of June. There is also $2 billion in funding earmarked for the COVAX programme led by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), the White House said.

GAVI and the WHO welcomed the initiative.

Washington is also taking steps to support local production of COVID-19 vaccines in other countries, including through its Quad initiative with Japan, India and Australia.

(Reporting by Steve Holland in St. Ives, England, Andrea Shalal in Washington and Caroline Copley in Berlin; Writing by Guy Faulconbridge and Keith Weir;Editing by Leslie Adler, David Evans, Emelia Sithole-Matarise, Giles Elgood and Jane Merriman)

Continue Reading

Health

Vaccines donated by the United States and China

Published

 on

Both the United States and China have pledged large donations of COVID-19 vaccines to countries around the world. Washington has promised 80 million doses, three-quarters of which will be delivered via the international vaccine initiative COVAX, in what has been seen as an effort to counter China’s widening vaccine diplomacy. It began deliveries last week.

China had shipped vaccines to 66 countries in the form of aid, according to state news agency Xinhua. Beijing has not disclosed an overall figure for its donations but Reuters calculations based on publicly available data show at least 16.57 million doses have been delivered. China has also pledged to supply 10 million doses to COVAX.

VACCINES DONATED BY U.S. (plan for the first 25 mln):

Regional partners and priority recipients

COUNTRY/TERRITORY PLEDGED DELIVERED

Including Canada, Mexico, 1 mln to S.Korea in June

South Korea, West Bank and

Gaza, Ukraine, Kosovo,

Haiti, Georgia, Egypt,

Jordan, India, Iraq, Yemen,

United Nations

TOTAL 6 mln 1 mln

Allocations through COVAX

South and Central America

COUNTRY/TERRITORY PLEDGED DELIVERED

Brazil, Argentina, Colombia,

Costa Rica, Peru, Ecuador,

Paraguay, Bolivia,

Guatemala, El Salvador,

Honduras, Panama, Haiti,

Dominican Republic and other

Caribbean Community

(CARICOM) countries

TOTAL 6 mln

Asia

COUNTRY/TERRITORY PLEDGED DELIVERED

India, Nepal, Bangladesh,

Pakistan, Sri Lanka,

Afghanistan, Maldives,

Malaysia, Philippines,

Vietnam, Indonesia,

Thailand, Laos, Papua New

Guinea, Taiwan, and the

Pacific Islands

TOTAL 7 mln

Africa

COUNTRY/TERRITORY PLEDGED DELIVERED

To be selected in

coordination with the

African Union

TOTAL 5 mln

VACCINES DONATED BY CHINA (source – Reuters calculations and official data):

Asia Pacific

COUNTRY/TERRITORY PLEDGED DELIVERED

Afghanistan 400,000

Bangladesh Second batch of First batch of 500,000 delivered

600,000 on May 12

Brunei 52,000 in Feb

Cambodia 1.7 mln as of April 28

Kyrgyzstan 150,000 in March

Laos 300,000 in Feb

800,000 in late March

300,000 in late April

Maldives 200,000 in early March

Mongolia 300,000 in late February

Myanmar 500,000 in early May

Nepal 800,000 in late March

1 mln in early June

Pakistan 500,000 in early Feb

250,000 in Feb

500,000 in March

Philippines 600,000 in late Feb

400,000 in late March

Sri Lanka 600,000 at end March

500,000 in late May

Thailand 500,000 in May

500,000 in June

Timor-Leste 100,000 100,000 in early June

TOTAL 11.052 million

Africa

COUNTRY/TERRITORY PLEDGED DELIVERED

Angola 200,000 in late March

Algeria 200,000 200,000 in Feb

Botswana 200,000 in April

Cameroon 200,000 in April

Congo 100,000 100,000 in March

Egypt 600,000 in March

Ethiopia 300,000 in late March

Equatorial Guinea 100,000 in Feb

Guinea 200,000 in early March

Mozambique 200,000 in late Feb

Namibia 100,000 by early April

Niger 400,000 in late March

Sierra Leone 240,000 by late May

Togo 200,000 in April

Uganda 300,000

Zimbabwe 200,000 in Feb

200,000 in March

100,000 in May

TOTAL 3.74 million

South America

COUNTRY/TERRITORY PLEDGED DELIVERED

Bolivia 100,000 in late Feb

100,000 in late March

Venezuela 500,000 in early March

TOTAL 700,000

Europe & Middle East

COUNTRY/TERRITORY PLEDGED DELIVERED

Belarus 100,000 in Feb

300,000 in May

Georgia 100,000 at end April

Iran 250,000 at end February

Iraq 50,000 in early March

Montenegro 30,000 in early March

North Macedonia 100,000 in May

Syria 150,000 in late April

TOTAL 1.08 million

 

(Reporting by Roxanne Liu and Ryan Woo in Beijing and Cooper Inveen in Dakar; Additional reporting by MacDonald Dzirutwe in Harare, Asif Shahzad in Islamabad, Gopal Sharma in Kathmandu; Editing by Edwina Gibbs)

Continue Reading

Health

Coronavirus Worldwide right now

Published

 on

Here’s what you need to know about the coronavirus now:

Australia’s Melbourne to exit lockdown

Australia’s second largest city Melbourne will exit a hard lockdown as planned on Thursday night, Victoria state authorities said, although some restrictions on travel and gatherings would likely remain for another week.

After two weeks in a strict lockdown that forced people to remain at home except for essential business, Melbourne’s five million residents will get more freedom to step outside from 11:59 p.m. local time (1359 GMT) on Thursday.

However, people must stay within 25 km (15 miles) of their homes, officials said, in an effort to stop transmission during an upcoming long weekend. There will also be a total ban on house gatherings and masks will be mandatory indoors.

Deliveries of Thai-made AstraZeneca vaccines delayed

Malaysia and Taiwan are expecting deliveries of AstraZeneca vaccines manufactured in Thailand to be delayed, officials said, the latest countries to report a holdup with orders from the Thai plant.

The delay comes amid concerns over AstraZeneca’s distribution plans in Southeast Asia, which depends on 200 million doses made by Siam Bioscience, a company owned by Thailand’s king that is making vaccines for the first time.

Any questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner. Insulting Thailand’s monarchy is a crime punishable by up to 15 years in prison.

Indonesia aims to speed up vaccinations

President Joko Widodo said on Wednesday he hoped Indonesia’s vaccination rollout will hit one million shots a day by July, as authorities opened up inoculations to anyone aged over 18 in Jakarta to contain increased transmission in the capital.

Health officials in the world’s fourth most populous country, which aims to vaccinate 181.5 million people by next year, are trying to speed up the rollout after facing some supply issues.

The president said he wanted vaccinations to hit a targeted 700,000 doses a day this month and then rise again.

Singapore finds Delta most prevalent among variants

Singapore has found the Delta variant of the coronavirus to be the most prevalent among local cases of variants of concern (VOCs), according to health ministry data, highlighting its level of infectiousness.

There were 449 local cases with VOCs as of May 31, of which 428 were the Delta variant first detected in India and nine of the Beta variant first identified in South Africa.

Singapore reported its 34th death due to COVID-19, taking its toll from the pandemic beyond the 33 casualties recorded during the 2003 Severe Acute Respiratory Syndrome outbreak.

U.S. forming expert groups on lifting travel restrictions

The Biden administration is forming expert working groups with Canada, Mexico, the European Union and the United Kingdom to determine how best to safely restart travel after 15 months of pandemic restrictions, a White House official said on Tuesday.

Another U.S. official said the administration will not move quickly to lift orders that bar people from much of the world from entering the United States because of the time it will take for the groups to do their work.

The groups will be led by the White House COVID Response Team and the National Security Council and include the Centers for Disease Control and other U.S. agencies.

 

(Compiled by Linda Noakes; Editing by Giles Elgood)

Continue Reading

Trending